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Dengue virus serotype 4 (DENV-4) reemerged in 
Roraima State, Brazil, 28 years after it was last detected 
in the country in 1982. To study the origin and evolution of 
this reemergence, full-length sequences were obtained for 
16 DENV-4 isolates from northern (Roraima, Amazonas, 
Pará States) and northeastern (Bahia State) Brazil during 
the 2010 and 2011 dengue virus seasons and for an 
isolate from the 1982 epidemic in Roraima. Spatiotemporal 
dynamics of DENV-4 introductions in Brazil were applied 
to envelope genes and full genomes by using Bayesian 
phylogeographic analyses. An introduction of genotype I into 
Brazil from Southeast Asia was confi rmed, and full genome 
phylogeographic analyses revealed multiple introductions 
of DENV-4 genotype II in Brazil, providing evidence for >3 
introductions of this genotype within the last decade: 2 from 
Venezuela to Roraima and 1 from Colombia to Amazonas. 
The phylogeographic analysis of full genome data has 
demonstrated the origins of DENV-4 throughout Brazil.
Dengue virus (DENV), a widespread arthropod-borne virus that commonly affects humans, belongs to the 
family Flaviviridae, genus Flavivirus, and is classifi ed into 
4 distinct serotypes (DENV 1–4). DENV is most prevalent 
in tropical and subtropical areas, where eco-epidemiologic 
conditions appear to sustain the virus. In particular, these 
regions harbor 2 competent DENV vectors (Aedes aegypti 
and A. albopictus mosquitoes) and have environments 
favorable for DENV (1). In past decades, the number of 
countries reporting DENV cases and those with endemic 
DENV has increased dramatically. These increases 
refl ect the expanding habitat of the Aedes spp. mosquito 
vectors, the poorly planned urbanization of many cities in 
developing countries, an increased number of susceptible 
human hosts, and the rapid spread of DENV serotypes 
through global human travel networks (2–4). According to 
the World Health Organization, ≈3 billion persons living 
in >100 countries are at risk of being infected at least once 
annually by 1 of the 4 DENV serotypes (4).
In Brazil, DENV-1–3 were responsible for ≈5 million 
cases of DENV infection during 1990–2009, resulting in 
>15,000 reported cases of dengue hemorrhagic fever and 
≈1,000 DENV-related deaths (5–7). DENV-4 reemerged 
in Brazil in 2010, 28 years after it was last detected in the 
country; the site of the reemergence was Roraima State, 
northern Brazil (8), the same state in which DENV-4 had 
last been detected in 1982 (9). Brazilian Ministry of Health 
data for 2010 and 2011 show there were 1,666,208 cases of 
DENV infection, including 26,659 severe cases and 1,097 
associated deaths (10).
We describe the genetic characterization and 
spatiotemporal patterns of spread for DENV-4 strains 
isolated from 4 Brazilian states: Pará, Amazonas, and 
Roraima in northern Brazil and Bahia in northeastern Brazil. 
To characterize the origins of DENV-4 reemergence, we 
performed discrete Bayesian phylogeographic analysis on 
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98 full-length DENV-4 genomes and compared the results 
with those of a similar analysis on 314 envelope gene 
sequences.
Material and Methods
Viral Strains
We included 16 DENV-4 isolates in this study 
(Table). The viruses corresponded to low-passage virus 
strains (passage no. 1) from C6/36 cells obtained from the 
Department of Arbovirology and Hemorrhagic Fevers, 
Instituto Evandro Chagas, Brazilian Ministry of Health 
(Ananindeua, Brazil).
Sequencing, Assembly, and Accession Numbers
Nearly complete genome sequences were obtained 
by using high-throughput sequencing on a GS FLX+ 
System (454 Life Sciences, Branford, CT, USA) as 
described (11). The sequences of the 5′ and 3′ termini 
were obtained by using 5′ and 3′ rapid amplifi cation of 
cDNA ends  systems (Invitrogen, Carlsbad, CA, USA), 
according to the manufacturer’s instructions, with the 
following specifi c sets of primers: DENV-4 5′SP1 
(5′-AKCCCTGTCTTGGGTCCAGC-3′), DENV-4 5′SP2 
(5′- TTGAACGCCTCTTGAAGGTC-3′), DENV-4 5¢SP3 
(CTCTTGAAGGTCCAGGTCTA), DENV-4 3′SP1 
(5′-ATATCTGAATGGCAGCCATC-3′), and DENV-4 
3′SP2 (5′-TCACTGGCTGTTTCTTCTGCT-3′). All 5′ and 
3′ rapid amplifi cation of cDNA ends amplicons were cloned 
into a plasmid bacterial system by using the TOPO TA 
Cloning Kit (Invitrogen) and directly sequenced (in both 
directions) by using the ABI Prism BigDye Terminator 
v1.1 Cycle Sequencing Kit on an ABI Prism 3130 DNA 
analyzer (Applied Biosystems, Foster City, CA, USA) with 
the M13F/M13R set of primers (Invitrogen).
Data generated by the GS FLX+ System and ABI 
3130 platforms were assembled by using the mapping 
reference method as implemented by the GS Reference 
Mapper Program (available in Newbler v.2.6 software, 
http://454.com/products/analysis-software/index.asp). The 
mapper program was used to rearrange the reads against 
a given reference sequence by using the following default 
parameters: input = 20 bp, all contig threshold = 100, large 
contig threshold = 200, minimum overlap length = 40, 
minimum overlap identity = 70%, k-mer = 12 (seed step), 
and k-mer = 16 (seed length). A total of 16 new full-
length DENV-4 sequences were obtained and deposited in 
GenBank (accession nos. JQ513330–JQ513345).
Nucleotide Data Compilation and Alignment
We complemented our data with available full genome 
and envelope protein sequences for a total of 98 full 
genome (10,624 nt) and 314 full-length DENV-4 envelope 
protein (1,485 nt) sequences. These included 18 sequences 
from Brazil (3 from Belém, Pará State; 1 from Santarém, 
Pará State; 5 from Manaus, Amazonas State; 8 from Boa 
Vista, Roraima State; and 1 from Salvador, Bahia State); 
26 full genome and 75 envelope protein sequences from 
the Caribbean region (Puerto Rico, Dominica, Dominican 
Republic, Jamaica, Puerto Rico, Trinidad and Tobago, 
Barbados, Montserrat, Martinique, and Bahamas); 8 full 
genome and 10 envelope protein sequences from Colombia; 
34 full genome and 48 envelope protein sequences 
from Venezuela; 9 full genome and 88 envelope protein 
sequences from Mainland Southeast Asia (Thailand-
Bangkok, Vietnam, Cambodia, Myanmar, and Peninsular 
Malaysia); and 3 full genome and 22 envelope protein 
sequences from Maritime Southeast Asia (Philippines, 
Indonesia, Singapore, and East Malaysia).
We aligned the sequences by using MAFFT (12). 
After we manually edited the resulting alignment by 
using Se-Al (13), the total lengths of the full genome and 
envelope protein alignments consisted of 10,624 bp and 
1,485 bp, respectively. All sequences were screened for 
recombination by using the Phi-test (14), which is available 
in the SplitsTree4 program (15).
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Table. Dengue virus type 4 strains isolated in Brazil used for genetic characterization and phylogeographic analyses 
Identification Strain Year of isolation Municipality, state, of isolation GenBank accession no.
ROR 7542? Be H 774846? 2010 Boa Vista, Roraima JQ513333 
ROR 7591? Be H 780090? 2010 Boa Vista, Roraima JQ513340 
ROR 7620? Be H 780120? 2010 Boa Vista, Roraima JQ513341 
ROR 7357? Be H 772846? 2010 Boa Vista, Roraima JQ513330 
ROR 7363? Be H 772852? 2010 Boa Vista, Roraima JQ513331 
ROR 7365? Be H 772854? 2010 Boa Vista, Roraima JN559741 
STM 31? Be H 775222? 2010 Santarém, Pará JQ513334 
BEL 83791? Be H 778494? 2011 Belém, Pará JQ513335 
BEL 83846? Be H 778887? 2011 Belém, Pará JQ513337 
BEL 83804? Be H 778504? 2011 Belém, Pará JQ513336 
AM 5079? Be H 779652? 2011 Manaus, Amazonas JQ513339 
AM 5105? Be H 780571? 2011 Manaus, Amazonas JQ513344 
AM 4963? Be H 779228? 2011 Manaus, Amazonas JQ513338 
AM 5090? Be H 780556? 2011 Manaus, Amazonas JQ513342 
AM 5097? Be H 780563? 2011 Manaus, Amazonas JQ513343 
BHI 3681? Be H 781363? 2011 Salvador, Bahia JQ513345 
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Evolutionary Reconstruction of DENV-4 Dispersal
The parameters of a full probabilistic model of 
evolutionary history, including timed sequence evolution 
and spatial dispersal, were estimated by using a discrete 
Bayesian asymmetric diffusion approach (16) implemented 
in the BEAST software package (13,17). We used the 
Bayesian skyride model (18) as a fl exible tree prior and 
a general time-reversible model with a discretized gamma 
distribution (general time-reversible + 4Γ) to account for 
among-site rate variation. To calibrate the time scale of 
the trees, we obtained isolation dates (in years) from the 
GenBank annotations, and to accommodate rate variation 
among lineages, we used a lognormal relaxed molecular 
clock approach (19).
This approach enabled us to estimate ancestral spatial 
locations throughout the phylogenetic history while 
accounting for uncertainty in the phylogenetic and diffusion 
process (17). For the full genome and envelope protein 
datasets, 3 Markov-chain Monte Carlo analyses were 
run for 50 million states and sampled once every 10,000 
states. We used the BEAGLE library (13) together with 
BEAST (13) to augment the computational speed. After 
we removed 10% of the burn-in, we combined the runs 
by using LogCombiner (www.molecularevolution.org/
software/phylogenetics/beast). Maximum clade credibility 
(MCC) trees were summarized by using TreeAnnotator 
and visualized by using FigTree (12). We use the SPREAD 
application (20) to visualize and convert the estimated 
divergence times and spatial estimates annotated in the 
MCC trees to a keyhole markup language fi le (the fi les 
are available from authors upon request). All evolutionary 
parameters are reported as posterior means along with their 
95% Bayesian credibility intervals.
To obtain the expectations for the location state 
transitions, we estimated Markov jump counts (18,21) along 
the branches of the posterior tree distribution (22). We 
applied kernel density estimation in R to summarize Markov 
jump densities through time from particular locations.
Results
Asian DENV-4 Genotype I in Northern Brazil
The analysis (Phi-test implemented in SplitsTree) 
of the 98 DENV-4 full genomes did not provide support 
for recombination. Therefore, all 98 complete nucleotide 
(10,624 nt) and 314 (1,485 nt) envelope protein sequences 
were included in the Bayesian phylogeographic analyses 
by using a discrete asymmetric diffusion model and a 
fl exible demographic prior (online Technical Appendix 
Table, wwwnc.cdc.gov/EID/pdfs/12-0217-Techapp.pdf).
The complete genome and envelope protein MCC 
genealogies confi rmed that 3 major phylogenetic groups 
were compatible with the genotypes currently established for 
DENV-4: genotypes I–III (Figure 1). In particular, genotype 
I (n = 5 full genome, n = 85 envelope protein sequences) 
included strains that were isolated in Southeast Asia and a 
unique strain (BHI 3581 Be H 781363) that was isolated 
from an autochthonous febrile patient in 2011 in Salvador, 
Bahia State. The dense sampling in the envelope protein 
dataset made it possible for us to establish a relatively recent 
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Figure 1. Maximum clade credibility tree 
demonstrating the phylogenetic relationships 
of the 314 dengue virus type 4 (DENV-4) 
envelope genes (1,485 nt). The major groups 
(genotypes I–III) are indicated. Branch 
lengths are scaled in time units; scale bars, 
representing the chronology of DENV-4 
emergence, are color-coded according to 
the most probable geographic location of the 
descendent node. Introductions of DENV-4 
in Brazil are indicated by numbered circles; 
numbering follows the temporal order of the 
mean estimate of divergence time for that 
particular sequence or clade. In selected 
nodes, * indicates posterior probability 
support of 1.00. Panel on right shows a detail 
of the maximum clade credibility tree (built 
by using an alignment of 98 DENV-4 full 
genomes [10,624 nt]) that reveals 3 distinct 
well-supported introductions of genotype II 
cluster from neighboring South American 
countries into Brazil. SE, Southeast; RO, 
Roraima State; PA, Pará State; AMA, 
Amazonas State. A color version of this 
fi gure is available online (wwwnc.cdc.gov/
EID/article/18/11/12-0217-F1.htm).
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common ancestor with an Asian genotype I dating back to 
2004 (95% Bayesian credible interval [BCI] 2002–2007). 
In particular, results from the genomic and envelope protein 
phylogeographic analyses confi rmed with high posterior 
probability (>0.99) that the Brazilian strain from Bahia was 
introduced from Mainland Southeast Asia.
Multiple Introductions of DENV-4 Genotype II in Brazil
Genotype II (n = 86 full genome, n = 223 envelope 
protein sequences) included the other 17 strains sampled 
in Brazil (Municipalities of Manaus, Belém, Santarém, 
and Boa Vista) and in Venezuela, Colombia, Central 
America, the Caribbean, and Southeast Asia. Genotype III 
(n = 2 full genome, 4 envelope protein sequences) included 
strains that were exclusively isolated from Southeast Asia 
(Thailand). On the basis of the envelope gene analysis, 
we reconstructed 3 introductions of genotype II DENV-4 
in Brazil (Figure 1, left panel). First, the envelope protein 
MCC tree indicated a Brazilian cluster of strains identifi ed 
in Boa Vista and Manaus as part of the major South 
American genotype II cluster. Second, the full genome 
MCC tree broke the cluster in Boa Vista and Manaus 
into 3 different lineages in the same genotype II cluster. 
Third, the large South American genotype II cluster, as 
part of the full genome MCC genealogy (Figure 1, right 
panel), indicates additional introductions of genotype II 
into Brazil. Thus, we identifi ed a total of 6 introductions 
of DENV-4 in Brazil.
The most recent common ancestor of genotypes I–
III is believed to have a Southeast Asian origin (7). In 
line with recent fi ndings (23), we estimate that genotype 
II, the predominant genotype, was likely fi rst introduced 
into the Americas (Caribbean region) around 1978 (95% 
BCI 1976–1979) (Figure 1; online Technical Appendix 
Figure). Following a period of circulation in the Caribbean 
region, this genotype independently entered South 
American countries >4 times, as inferred respectively by 
the full genome and envelope protein analyses. Most of 
these introductions into South America seem to have led 
to relatively shallow phylogenetic clusters that probably 
refl ect short-term survival of the virus in South America.
Nevertheless, our data provide support for a major 
genotype II cluster that refl ects the successful establishment 
of this genotype in South American countries neighboring 
Brazil in or around 1994 (95% BCI 1992–1995). From 
Venezuela and Colombia, the genotype spread to Brazil 
>3 times in the last decade, as inferred by the full genome 
phylogeographic analyses (Figure 1, right panel). In 
contrast, the DENV-4 outbreak in Pará State (Santarém and 
Belém) was identifi ed around 2008 (95% BCI 2006–2009) 
and is directly linked to strains from the Caribbean region. 
Overall, we found >3 distinct DENV-4 introductions into 
Roraima State: 1 from the Caribbean region ≈3 decades 
ago (indicated as 1 in Figure 1, left panel), and 2 from the 
strain that has become endemic in Venezuela within the 
last decade (indicated as 3 and 5 in Figure 1, right panel). 
One of these strains resulted in a well-supported cluster 
that dated back to about 2006 (95% BCI 2005–2007) and 
comprised 6 strains.
Global Patterns of DENV-4 Dissemination
To identify the major export and import locations for 
DENV-4 at a global scale, we summarized the number of 
introductions from and to each of the locations that were 
estimated by using Markov jump count approaches as part 
of the full genome analysis (Figure 2, panel A). Our results 
pinpoint Maritime Southeast Asia, the Caribbean region, 
and Venezuela as the 3 most prominent sources of DENV-
4 export. In addition, to investigate the temporal dynamics 
of viral dispersal from the 3 locations in the evolutionary 
history of DENV-4, we estimated the Markov jump density 
from these locations through time (Figure 2, panel B). 
We distinguished different peaks, which appear to refl ect 
3 distinct waves of DENV-4 migration; the most recent 
wave corresponded to exportations from South American 
countries bordering Brazil, particularly Venezuela, where 
DENV-4 has been established longer.
After an initial establishment in the Caribbean region, 
genotype II most likely fi rst dispersed to Brazil (Roraima 
State), Venezuela, Colombia, and, more recently, to Brazil 
(Belém, Pará State) again (Figure 3). Locations such 
as Santarém, Pará State, and Manaus, Amazonas State, 
do not have a direct relation to the Caribbean locations; 
instead, the strain found in Santarém is linked to a cluster of 
sequences from other locations in Pará State. This fi nding 
further indicates that there is ongoing circulation of DENV-
4 within Brazil. Nevertheless, most recent introductions of 
genotype II in Brazil in the last decade seem to have been 
fueled by strains originating from bordering countries.
Discussion
DENV-4 was not detected in Brazil for 28 years 
after the fi rst clinical and laboratory reports of dengue 
fever cases in Roraima State during 1981–1982 (9). Since 
then, no additional cases were reported in the country 
until the reemergence of DENV-4 in Boa Vista, Roraima 
State, in 2010 (8). Following those fi rst recent detections 
of DENV-4 in Brazil, the virus was identifi ed in 2011 in 
the northern Brazilian states of Amazonas, Amapá, and 
Pará. Furthermore, DENV-4 was serologically detected in 
persons in several other states, demonstrating the potential 
for this virus to spread quickly to several regions (8).
Since the fi rst detection of DENV-4 in Brazil in 1982 
(8,9), partial genomic studies have confi rmed that the 
original virus was directly associated with the Caribbean 
strains, which are known as genotype II. Genotype II has 
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been responsible for several outbreaks in many countries in 
the Caribbean and South America (8,24–28). Phylogenetic 
analyses of different strains demonstrated the presence of 
2 distinct genotypes (genotypes I and II) of DENV-4 in 
Brazil. The introduction of a new serotype and a distinct 
DENV-4 genotype (Asian genotype I) into Brazil after 
nearly 3 decades of no circulation highlights the potential 
for future outbreaks of genotype I in this country. The 
presence of a serotype against which the population is 
not immunized indicates that the country is at risk for a 
sharp increase in the number of dengue virus infections, 
including severe cases (8).
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Figure 3. Overview of spatiotemporal dispersal of dengue virus type 4 (DENV-4) from Southeast (SE) Asia to the Caribbean region and 
then to South America. Links between geographic locations represent phylogeny branches of the full genome maximum clade credibility 
tree, as projected by using SPREAD software (20). The time gradient is coded to the arrows and depicts the relative time elapsed since the 
earliest inferred viral migration out of Southeast Asia (i.e., 1978, 95% Bayesian credible interval 1977–1980). Introductions are numbered 
as in Figure 1. Medium gray indicates the presence of DENV-4 where genomic data were available; dark gray indicates sampled countries 
where complete genomic sequence data were available; white indicates no genomic data available; and circles indicate sampled locations 
and are colored according to the earliest migration that was detected from the sink location. RO, Roraima State; AMA, Amazonas State. A 
color version of this fi gure is available online (wwwnc.cdc.gov/EID/article/18/11/12-0217-F2.htm).
Figure 2. A) Estimated number of dengue virus type 4 exportations and importations (mean and 95% Bayesian credible intervals) (A). 
The full genome dataset was used and available data were discretized for countries neighboring Brazil. SE, Southeast. B) Markov jump 
density of viral exportations over time for the 3 major exporters of dengue virus type 4 (black line, Maritime Southeast Asia; dark gray line, 
Caribbean region; and light gray line, Venezuela).
Dengue Virus Serotype 4, Brazil, 2010–2011
The phylogeographic analyses of full genomes and 
envelope genes confi rmed the co-circulation of 2 distinct 
DENV-4 genotypes (I and II) in Brazil. Genotype II is most 
common in South America and the Caribbean region, and 
genotype I was represented by 1 strain isolated from Bahia 
State in northeastern Brazil. The analyses also confi rmed 
the introduction of DENV-4 into Pará State from the 
Caribbean region and suggest that this introduction is very 
recent (online Technical Appendix Figure).
Previous phylogenetic analyses have been performed 
on partial and a few complete DENV-4 genomes (8,29–31). 
The results we obtained by using the new set of complete 
genomes suggest that DENV-4 genotype II emerged and 
reemerged in Brazil from >3 distinct origins (Southeast 
Asia, the Caribbean region, and Venezuela), which 
demonstrates a dispersal pattern in Brazil that is far more 
complex than expected from standard epidemiologic data.
We demonstrate that full genome analysis complements 
the analysis of more widely available envelope protein 
sequences. Although a dense sampling may have its own 
particular benefi ts for divergence time and spatial diffusion 
estimation, full genomes can provide more phylogenetic 
resolution to unravel individual introductions from 
populations of closely related strains.
Our results indicate that DENV-4 was exported 
multiple times from the Caribbean region to northern 
South American locations before the virus became 
established in South America. Overall, the spatiotemporal 
patterns of DENV-4 revealed in South America over a long 
time scale are reminiscent of a source-sink model of virus 
dispersal (32), in which the location of primary source 
virus populations shifted from Maritime Southeast Asia to 
the Caribbean region and, most recently, to northern South 
America, albeit with co-circulation in each location. This 
dispersal pattern differs from the source-sink dynamics of 
seasonal infl uenza, in which each epidemic wave seems 
to be caused by emergence from the same source (33). 
Active molecular epidemiologic surveillance will be 
essential for better characterizing local source populations 
of DENV-4.
In conclusion, we found that 2 distinct genotypes 
(I and II) of DENV-4 are circulating in Brazil, and we 
provide insight into the origin and dispersal of the DENV 
throughout northern Brazil and areas of several South 
American countries. Further studies are needed to analyze 
complete genomes from other countries to which DENV-
4 is endemic; such studies will more fully elucidate the 
geographic dispersal dynamics of DENV-4 in regions of 
the Americas where it is endemic.
This study was supported by Conselho Nacional de 
Desenvolvimento Científi co e Tecnológico (CNPq) grants 
(302987/2008-8 and 301641/2010-2) and a CNPq/Coordenação 
de Aperfeiçoamento de Pessoal de Nível Superior/Fundação de 
Amparo a Pesquisa do Estado do Pará grant (573739/2008-0). 
N.R.F. is supported by Fundação para a Ciência e Tecnologia 
(grant SFRH/BD/64530/2009). M.A.S. is partially supported by 
the National Science Foundation (grant DMS0856099. A.B.A. is 
supported by Fundação para a Ciência e Tecnologia (grant SFRH/
BPD/65605/2009). M.A.S. and P.L. had fi nancial support from 
the European Research Council under the European Community’s 
Seventh Framework Program (FP7/2007-2013; under grant 
278433-PREDEMICS and ERC grant 260864). The collaboration 
between M.R.T.N., N.R.F., and A.B.A. was supported by the 
Network of the Portuguese-Speaking Countries Community, 
Instituto de Higiene e Medicina Tropical, Universidade Nova de 
Lisboa, Lisboa, Portugal.
Dr Nunes is a molecular biologist at the Instituto Evandro 
Chagas, Ananindeua, Brazil. His primary research interests are 
molecular epidemiology and phylogenetic and evolutionary 
aspects of arboviruses, hantaviruses, and other microbial agents.
References
  1.  Gubler DJ. Dengue and dengue hemorrhagic fever: its history and 
resurgence as a global public health problem. In: Gubler DJ, Kuno 
G, eds. Dengue and dengue hemorrhagic Fever. New York: CAB 
International; 1997. p. 1–22.
  2.  Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 
2002;324:1563–6. http://dx.doi.org/10.1136/bmj.324.7353.1563
  3.  Lindbäck H, Lindbäck J, Tegnell A, Janzon R, Vene S, Ekdahl K. 
Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect 
Dis. 2003;9:438–42. http://dx.doi.org/10.3201/eid0904.020267
  4.  World Health Organization. Dengue fever and dengue hemorrhagic 
fever. Geneva: the Organization; 2009.
  5.  Ministério da Saúde/Secretara de Vigilância em Saúde MS/SVS. 
Dengue cases Technical report; 2009 [in Portuguese] [cited 2011 
Dec 17]. http://portal.saude.gov.br/portal/arquivos/pdf/boletim_
dengue_informe11maio.pdf
  6.  Teixeira MG, Barreto ML, Costa MCN, Ferreira LDA, Vasconcelos 
PFC, Cairncross S. Dynamics of dengue virus circulation: a silent 
epidemic in a complex urban área. Trop Med Int Health. 2002;7:757–
62. http://dx.doi.org/10.1046/j.1365-3156.2002.00930.x
  7.  Dussart P, Baril L, Petit L, Beniguel L, Quang LC, Ly S, et al. 
Clinical and virological study of dengue cases and the members 
of their households: the multinational DENFRAME project. PLoS 
Negl Trop Dis. 2012;6:e1482. http://dx.doi.org/10.1371/journal.
pntd.0001482
  8.  Temporão JG, Penna GO, Carmo EH, Coelho GE, do Socorro Silva 
Azevedo R, Teixeira Nunes MR, et al. Dengue virus serotype 4, 
Roraima State, Brazil. Emerg Infect Dis. 2011;17:938–40. http://
dx.doi.org/10.3201/eid1705.101681
  9.  Osanai CH, Travassos da Rosa AP, Tang AT, do Amaral RS, 
Passos AD, Tauil PL. Dengue outbreak in Boa Vista, Roraima [in 
Portuguese]. Rev Inst Med Trop Sao Paulo. 1983;25:53–4.
10.  Ministério da Saúde/Secretaria de Vigilância em Saúde MS/SVS. 
Sempre é hora de combater a dengue [cited 2011 Dec 17]. http://
www.combatadengue.com.br/
11.  Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben 
LA, et al. Genome sequencing in microfabricated high-density 
picolitre reactors. Nature. 2005;437:376–80.
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 11, November 2012 1863
RESEARCH
12.  Katoh K, Kuma K, Toh T, Miyata T. MAFFT version 5: improvement 
in accuracy of multiple sequence alignment. Nucleic Acids Res. 
2005;33:511–8. http://dx.doi.org/10.1093/nar/gki198
13.  Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian 
phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 
2012;29:1969–73. http://dx.doi.org/10.1093/molbev/mss075
14.  Bruen TC, Philippe H, Bryant D. A simple and robust statistical 
test for detecting the presence of recombination. Genetics. 
2006;172:2665–81. http://dx.doi.org/10.1534/genetics.105.048975
15.  Huson DH, Bryant D. Application of phylogenetic networks in 
evolutionary studies. Mol Biol Evol. 2006;23:254–67. http://dx.doi.
org/10.1093/molbev/msj030
16.  Edwards CJ, Suchard MA, Lemey P, Welch JJ, Barnes I, Fulton 
TL, et al. Ancient hybridization and an Irish origin for the modern 
polar bear matriline. Curr Biol. 2011;21:1251–8. http://dx.doi.
org/10.1016/j.cub.2011.05.058
17.  Lemey P, Rambaut A, Drummond AJ, Suchard MA. 
Bayesian phylogeography fi nds its roots. PLOS Comput Biol. 
2009;5:e1000520. http://dx.doi.org/10.1371/journal.pcbi.1000520
18.  Minin VN, Suchard MA. Counting labeled transitions in continuous-
time Markov models of evolution. J Math Biol. 2008;56:391–412. 
http://dx.doi.org/10.1007/s00285-007-0120-8
19.  Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed 
phylogenetics and dating with confi dence. PLoS Biol. 2006;4:e88. 
http://dx.doi.org/10.1371/journal.pbio.0040088
20.  Bielejec F, Rambaut A, Suchard MA, Lemey P. SPREAD: 
spatial phylogenetic reconstruction of evolutionary dynamics. 
Bioinformatics. 2011;27:2910–2. http://dx.doi.org/10.1093/
bioinformatics/btr481
21.  Talbi C, Lemey P, Suchard MA, Abdelatif E, Elharrak M, Nourlil J, 
et al. Phylodynamics and human-mediated dispersal of a zoonotic 
virus. PLoS Pathog. 2010;6:e1001166. http://dx.doi.org/10.1371/
journal.ppat.1001166
22.  O’Brien JD, Minin VN, Suchard MA. Learning to count: robust 
estimates for labeled distances between molecular sequences. Mol 
Biol Evol. 2009;26:801–14. http://dx.doi.org/10.1093/molbev/
msp003
23.  Allicock OM, Lemey P, Tatem AJ, Pybus OG, Bennett SN, Mueller 
BA, et al. Phylogeography and population dynamics of dengue 
viruses in the Americas. Mol Biol Evol. 2012;29:1533–43. http://
dx.doi.org/10.1093/molbev/msr320
24.  Centers for Disease Control and Prevention. Dengue type 4 
infections in US travelers to the Caribbean. MMWR Morb Mortal 
Wkly Rep. 1981;30:249–50.
25.  Forshey BM, Morrison AC, Cruz C, Rocha C, Vilcarromero S, 
Guevara C, et al. Dengue virus serotype 4, northeastern Peru, 2008. 
Emerg Infect Dis. 2009;15:1815–8. http://dx.doi.org/10.3201/
eid1511.090663
26.  Fernández J, Vera L, Tognarelli J, Fasce R, Araya P, Villagra E, et al. 
Detection of dengue virus type 4 in Easter Island, Chile. Arch Virol. 
2011;156:1865–8. http://dx.doi.org/10.1007/s00705-011-1049-1
27.  Nogueira RM, Eppinghaus AL. Dengue virus type 4 arrives in the 
state of Rio de Janeiro: a challenge for epidemiological surveillance 
and control. Mem Inst Oswaldo Cruz. 2011;106:255–6.
28.  Shu PY, Su CL, Liao TL, Yang CF, Chang SF, Lin CC, et al. 
Molecular characterization of dengue viruses imported into Taiwan 
during 2003–2007: geographic distribution and genotype shift. Am J 
Trop Med Hyg. 2009;80:1039–46.
29.  Lanciotti RS, Gubler DJ, Trent DW. Molecular evolution and 
phylogeny of dengue-4 viruses. J Gen Virol. 1997;78:2279–84.
30.  Dussart P, Lavergne A, Lagathu G, Lacoste V, Martial J, Morvan 
J, et al. Reemergence of dengue virus type 4, French Antilles and 
French Guiana, 2004–2005. Emerg Infect Dis. 2006;12:1748–51. 
http://dx.doi.org/10.3201/eid1211.060339
31.  de Souza RP, Rocco IM, Maeda AY, Spenassatto C, Bisordi I, Suzuki 
A, et al. Dengue virus type 4 phylogenetics in Brazil 2011: looking 
beyond the veil. PLoS Negl Trop Dis. 2011;5:e1439. http://dx.doi.
org/10.1371/journal.pntd.0001439
32.  Holmes EC. The evolutionary history and phylogeography of 
human viruses. Annu Rev Microbiol. 2008;62:307–28. http://dx.doi.
org/10.1146/annurev.micro.62.081307.162912
33.  Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger 
JK, Holmes EC. The genomic and epidemiological dynamics of 
human infl uenza A virus. Nature. 2008;453:615–9. http://dx.doi.
org/10.1038/nature06945
Address for correspondence: Pedro Fernando da Costa Vasconcelos, 
Departamento de Arbovirologia e Febres Hemorrágicas, Instituto Evandro 
Chagas, Ministério da Saúde, Rodovia BR-316 km-7, CEP: 67030-000, 
Ananindeua, Brazil; email: pedrovasconcelos@iec.pa.gov.br
1864 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 11, November 2012
